What's New
Last Posted: Nov 17, 2019
- Impact of Precision Medicine on Efficiencies of Novel Drug Development in Cancer
H Sarvas et al, JNCI, November 2019 - Can skin cancer diagnosis be transformed by AI?
A Esteva et al, Lancet Digital Health, November 2019 - Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care
A Penson et al,JAMA Oncology, November 14, 2019 - Risk-Adapted Starting Age of Screening for Relatives of Patients With Breast Cancer
T Mukama, et al. JAMA Oncology, November 14, 2019 - Toward Risk-Stratified Breast Cancer Screening: Considerations for Changes in Screening Guidelines
GL Gierach et al, JAMA Oncology, November 14, 2019 - Tumor Origins Through Genomic Profiles
ET Liu et al, JAMA Oncology, November 14, 2019 - Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures
I Sobhani, et al, PNAS, November 11, 2019 - Factors associated with oncologist discussions of the costs of genomic testing and related treatments.
Yabroff K Robin et al. Journal of the National Cancer Institute 2019 Nov - Guidelines for the management of hereditary colorectal cancer from the BSG /ACPGBI/UKCGG
British Society Gastroenterology, October 2019 - Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy
D Chowell et al, Nature Medicine, November 7, 2019 - Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.
Elsayegh Nisreen et al. Cancer medicine 2018 7(6) 2718-2726 - Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy.
Karnes R Jeffrey et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 24(16) 3908-3916 - Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in nasopharyngeal carcinoma.
Sabarimurugan Shanthi et al. PloS one 2019 14(2) e0209760 - CRISPR Approach To Fighting Cancer Called 'Promising' In 1st Safety Test
R Stein, NPR, November 6, 2019 - Crispr Takes Its First Steps in Editing Genes to Fight Cancer
D Grady, NY Times, November 6, 2019
.png)
No hay comentarios:
Publicar un comentario